Thien Dinh Email

Engineering Development Manager . AdvanCell

Current Roles

Employees:
35
Revenue:
$5.4M
About
AdvanCell is a radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au
AdvanCell Address

Sydney, null
AUS
AdvanCell Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.